Detailed company information
Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company, develops novel therapeutics for infectious disease in the United States. Its chronic Hepatitis B virus product pipeline comprises Imdusiran, conjugated GalNAc, subcutaneously-delivered RNAi therapeutic product candidate which is in phase 2a clinical trials that suppresses all HBV antigens, including HBsAg expression; and AB-101, an oral PD-L1 inhibitor, which is in phase 1a/1b clinical trial that has the potential to reawaken patients’ HBV-specific immune response by inhibiting PD-L1. The company has licensing agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize products with LNP delivery technology. The company was formerly known as Tekmira Pharmaceuticals Corporation and changed its name to Arbutus Biopharma Corporation in July 2015. Arbutus Biopharma Corporation was incorporated in 2005 is headquartered in Warminster, Pennsylvania.
Last Updated: Sep 2026
Earnings Transcript for 2024 - Q3Released: Nov 06, 2024
Earnings Transcript for 2024 - Q2Released: Aug 01, 2024
Earnings Transcript for 2024 - Q1Released: May 02, 2024
Earnings Transcript for 2023 - Q4Released: Feb 29, 2024
Earnings Transcript for 2023 - Q3Released: Nov 07, 2023
Earnings Transcript for 2023 - Q2Released: Aug 03, 2023
Earnings Transcript for 2023 - Q1Released: May 04, 2023
Earnings Transcript for 2022 - Q4Released: Mar 02, 2023
Earnings Transcript for 2022 - Q3Released: Nov 09, 2022
Earnings Transcript for 2022 - Q2Released: Aug 04, 2022
Earnings Transcript for 2022 - Q1Released: May 05, 2022
Earnings Transcript for 2021 - Q4Released: Mar 03, 2022
Earnings Transcript for 2021 - Q3Released: Nov 04, 2021
Earnings Transcript for 2021 - Q2Released: Aug 05, 2021
Earnings Transcript for 2021 - Q1Released: May 05, 2021
Earnings Transcript for 2020 - Q4Released: Mar 04, 2021
Earnings Transcript for 2020 - Q3Released: Nov 05, 2020
Earnings Transcript for 2020 - Q2Released: Aug 07, 2020
Earnings Transcript for 2020 - Q1Released: May 11, 2020
Earnings Transcript for 2019 - Q4Released: Mar 05, 2020
Earnings Transcript for 2019 - Q3Released: Nov 06, 2019
Earnings Transcript for 2019 - Q2Released: Aug 05, 2019
Earnings Transcript for 2019 - Q1Released: May 07, 2019
ARCT Arcturus Therapeutics Holdings Inc.
Dafinchi
